Custom-made stent grafts for complex aortic aneurysms that standard devices cannot treat
Tests custom-made and modified stent grafts in people with complex aortic aneurysms.
Key facts
- Who runs it
- Andres Schanzer
- Where
- Worcester, United StatesSee the site
- Trial code
- Registry title
- Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
- Status
- Recruiting
- People taking part
- 600 people, planned
- Started
- Mar 2014
- Expected to end
- Mar 2030
- Type of study
- Interventional
- Treatments tested
- Custom Made Fenestrated or Branched Stent Graft
- Record updated
- 22 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a complex aortic aneurysm (a bulge in the main artery) that standard approved stent grafts cannot treat. They must also be at high risk for open surgery.
- Age
- At least 18 years of age.
- Sex
- All sexes can join.
- Disease stage
- Aortic or aortoiliac aneurysm with diameter ≥5.5 cm (2.2 in), or growth ≥1.0 cm per year, or symptoms that call for repair. Symptomatic and unsafe to wait for a standard device. A cohort is open to people with Marfan, Ehlers-Danlos or Loeys-Dietz syndromes.
- Earlier treatment
- High surgical risk can come from previous abdominal surgery, previous left-sided thoracotomy or previous aortic surgery, among other factors.
Main reasons for not taking part
- Pregnant or breastfeeding.
- Life expectancy less than 2 years, including from active cancer.
- Allergy to stainless steel, polyester, polypropylene, solder, gold or nitinol, or severe contrast reaction that cannot be pre-medicated.
- Bleeding disorder that cannot be corrected, unstable angina, or infection that could spread to the graft.
- Artery shape or size that blocks the device, such as proximal neck length ≤25 mm.
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- A patient may be suitable for inclusion in the study if the patient has at least one of the following:; Aortic or aortoiliac aneurysm with diameter ≥5.5 cm; Aortic or aortoiliac aneurysm with a history of growth ≥1.0 cm per year, or clinical indication for aneurysm repair based on symptoms; General Inclusion Criteria; <!-- -->; Cannot be treated with a currently available non-modified approved device; Symptomatic on presentation and unsafe to wait for the time necessary to obtain a currently available non-modified approved device; At least 18 years of age; Not pregnant or breastfeeding; Willing and able to comply with five years of follow-up; Willing and able to provide informed consent prior to enrollment; No systemic or local infection that may increase the risk of endovascular graft infection; High risk for open surgical repair based on any of the factors below:; Anatomic i. Previous abdominal surgery ii. Previous left-sided thoracotomy (if the proposed open repair would require dissection of the thoracic aorta) iii. Previous aortic surgery b. Physiologic i. ASA Category III or higher ii. Age >70 years iii. Previous myocardial infarction, coronary artery disease, or coronary artery stent iv. Coronary stress test with a reversible perfusion defect v. Congestive heart failure vi. COPD
Who cannot take part
- Iliac artery diameter, measured inner wall to inner wall on a sectional image (CT) <7.0 mm at any point along access length (prior to deployment)
- Exclusion Criteria Medical Exclusion Criteria; Cultural objection to receipt of blood or blood products; Allergy or sensitivity to stainless steel, polyester, polypropylene, solder (tin, silver), gold, or nitinol; Anaphylactic reaction to contrast that cannot be adequately pre-medicated; Uncorrectable coagulopathy; Unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina); Patient has active malignancy with life expectancy of less than 2 years; Patient has life expectancy less than two years; Anatomical Exclusion Criteria
- Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access
- Proximal neck length ≤25 mm
- Proximal neck, measured outer wall to outer wall on a sectional image (CT); For use of Zenith Flex: diameter >32 mm or <18 mm; For use of Zenith TX2: diameter >38 mm or <24 mm (for proximal and distal neck diameter)
- Proximal neck angulated more than 60 degrees relative to the long axis of the aneurysm
- Proximal neck diameter change over the length of the proximal seal zone >4 mm
- Proximal seal site with a circumferential thrombus/atheroma
- Ipsilateral iliac artery fixation site diameter, measured inner wall on a sectional image (CT) >21 mm at distal fixation site
- Iliac artery distal fixation site <10 mm in length
- Non-bifurcated segment of any artery to be stented < 15 mm in length
- Artery to be stented with a maximum diameter <3 mm or >10 mm at the vessel ostium
- Inability to maintain at least one patent hypogastric artery
Where in United States
- UMass Memorial Health Care - University CampusWorcester, United StatesContact: Shauneen Valliere, MSN, NPTaking people
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the safety and efficacy of custom made devices, Zenith t-Branch devices and physician modification of FDA approved off-the-shelf endovascular grafts in the treatment of patients with complex abdominal aneurysms, aortoiliac aneurysms, thoracoabdominal aneurysms and aortic arch aneurysms who (1) have anatomy not suitable for endovascular repair using grafts currently marketed in the United States,(2) are deemed unsafe to wait the required time necessary for commercial endograft manufacturing, and (3) are at high risk for open surgical repair. Amendment to the study has created a cohort open to people with connective tissue diseases such as Marfan, Ehlers-Danlos or Loey-Dietz syndromes to enroll in the trial. An additional amendment to the study allows the use of a custom made device to treat an aneurysm in the aortic arch.
The group in the trial
- Endovascular repairTreatment being tested
Endovascular repair of Complex Aortic Aneurysm using a physician modified stent graft. custom made device or arch branch device.
Treatment: Custom Made Fenestrated or Branched Stent Graft
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
- Plain-language title
- Custom-made stent grafts for complex aortic aneurysms that standard devices cannot treatGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Differences in aortic remodeling in patients with type 1a and type 5 endoleak who undergo salvage with fenestrated/branched endovascular aortic repair.Journal of vascular surgery, 2025
- Multicenter Prospective Evaluation of Patient Radiation Exposure During Fenestrated-branched Endovascular Aortic Repair: A Ten-year Experience.Annals of surgery, 2026
- Trends and outcomes over time with fenestrated and branched endovascular aortic repair in the United States Aortic Research Consortium.Journal of vascular surgery, 2025
- Early and Late Aortic-Related Mortality and Rupture After Fenestrated-Branched Endovascular Aortic Repair of Thoracoabdominal Aortic Aneurysms: A Prospective Multicenter Cohort Study.Circulation, 2024
- Severity of acute kidney injury is associated with decreased survival after fenestrated and branched endovascular aortic aneurysm repair.Journal of vascular surgery, 2023
- Predictors and outcomes of spinal cord injury following complex branched/fenestrated endovascular aortic repair in the US Aortic Research Consortium.Journal of vascular surgery, 2023
- Initial single-center experience using Fiber Optic RealShape guidance in complex endovascular aortic repair.Journal of vascular surgery, 2023
- Lumbar drain complications in patients undergoing fenestrated or branched endovascular aortic aneurysm repair: Development of an institutional protocol for lumbar drain management.Journal of vascular surgery, 2020
- Record updated
- 22 October 2025